Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Return to: PBR Home | Contract Research & Services
Today in Contract Research & Services

Contract Research & Services

Bayer, Sprint Bioscience partner to develop new oncology drug candidates Bayer HealthCare has entered into a collaboration and license agreement with the Swedish company Sprint Bioscience to research, develop and commercialize oncology drug candidates. Contract Research & Services > Contract Research > News

Latest Contract Research & Services News by Sector

Select a sector from the list or browse by sector below:

Clinical Trials

MicuRX reports positive Phase II trial results for MRX-I to treat MRSA and VRE
By PBR Staff Writer
MicuRx Pharmaceuticals has reported positive top-line results from the first Phase II clinical trial for its lead drug MRX-I, an oral oxazolidinone antibiotic designed to treat drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).
Contract Research & Services > Clinical Trials > News
Symbiomix completes enrollment in second pivotal trial of SYM-1219 for bacterial vaginosis
Symbiomix announced the completion of patient enrollment in a Phase 3 clinical study, the second pivotal trial of SYM-1219, which is a single-dose, oral product candidate for the treatment of bacterial vaginosis (BV).
Contract Research & Services > Clinical Trials > News

Contract Research

ESC launches new concept for driving innovation in cardiovascular research with support from Boehringer
The European Society of Cardiology (ESC) announced the launch of the competitive medical research programme ‘ESC Grants for Medical Research Innovation’, exclusively supported by an independent grant from Boehringer Ingelheim.
Contract Research & Services > Contract Research > News
WuXi PharmaTech's STA subsidiary gets first approval from Japanese regulatory authorities
WuXi PharmaTech (Cayman), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, announced that its small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmaceutical (STA) received its first approval from the Japan PMDA for the manufacture of the GMP intermediate of a branded commercial drug in July.
Contract Research & Services > Contract Research > News

Contract Services

Celyad enter into license agreement with Medisun for C-Cure in Greater China
By PBR Staff Writer
Belgian biopharmaceutical firm Celyad has entered into a new collaboration and distribution agreement with its Hong-Kong based partner, Medisun International Limited (Medisun) for C-Cure, its lead cardiac disease cell therapy candidate.
Contract Research & Services > Contract Services > News
Recipharm to manufacture RedHill's RHB-105 to treat H. pylori infection
By PBR Staff Writer
Swedish contract development and manufacturing organization (CDMO) Recipharm has signed an agreement with Israeli biopharmaceutical firm RedHill Biopharma to manufacture its late-stage patented drug candidate, RHB-105 to treat Helicobacter pylori (H. pylori) bacterial infection.
Contract Research & Services > Contract Services > News